Where does Theravance Biopharma R&D IP, LLC rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Theravance Biopharma R&D IP, LLC ranks #1,711 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Theravance Biopharma R&D IP, LLC hold?

Theravance Biopharma R&D IP, LLC holds 239 US utility patents granted between 2015 and 2025, spanning 16 technology areas.

What is Theravance Biopharma R&D IP, LLC's Innovation Score?

Theravance Biopharma R&D IP, LLC has an Innovation Score of 46.5 out of 100 (top 21% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Theravance Biopharma R&D IP, LLC's patent grant rate increasing or decreasing?

Theravance Biopharma R&D IP, LLC's recent grant velocity is -34% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Theravance Biopharma R&D IP, LLC's patents?

Theravance Biopharma R&D IP, LLC's patents average 15.1 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Theravance Biopharma R&D IP, LLC patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Theravance Biopharma R&D IP, LLC

Q: What technology areas does Theravance Biopharma R&D IP, LLC focus on?

Theravance Biopharma R&D IP, LLC's top technology area is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations) with 229 patents. Grants appear in 16 CPC subclasses total.

USPTO PatentsView assignee record - 239 granted patents across 16 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Theravance ranks #1,711 of 49,997 tracked US assignees by granted-patent volume, with 239 patents across 16 technology areas.

#1,711
of 49,997 US assignees by volume: Top 21%
by Innovation Score (46.5/100): 15.1
avg claims per patent: -34%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R1711 · US Corporation #1,711 · 239 grants

GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-DOWN · BOOK-FULL

GRANTS-MID 239 grants
TOP-DECILE #1,711/49,997
PHOTO-FINISH Entit Software
CPC-FOCUS A61P · 16 areas
INNOV-PAR 46.5/100
CLAIMS-RICH 15.1 claims/avg
TYPE-USCORP US Corporation
VEL-DOWN -34% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Entit Software LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
ASP Global Manufactu… · near

46
Atlassian · near

46
Optim · near

46
Theravance Biopharma… · this assignee

46
Unity Semiconductor · near

46
3D Lighting… · lowest

7

What this shows Theravance's Innovation Score is 46.5/100 (top 21% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Theravance's grants concentrate

Theravance Biopharma R&D IP, LLC is a focused PatentsView assignee: 16 CPC subclasses with 95.8% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2015 (39 grants) versus a trough of 7 in 2024. By volume, Theravance sits between Dana Heavy Vehicle Systems Group, LLC and Children's Hospital Medical Center.

Theravance's three-year grant acceleration

From 2019–2021 to 2022–2024, Theravance Biopharma R&D IP, LLC moved from 73 to 48 grants (0.66x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #2,284. See the growth leaderboard.

Dana Heavy Vehicl…

240
Entit Software

239
Medtronic Xomed

239
Nikkiso

239
Vorwerk & Interho…

239
ZKW Group

239
Theravance Biopha… ◀

239
Alipay (Hangzhou)…

238
Children's Hospit…

238

What this shows Theravance holds 239 patents at rank #1,711, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Theravance

By rank, the assignees closest to #1,711 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Theravance's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Theravance, neither rank-band nor same-CPC leaders (those blocks stay above).

Similar innovation score

Nearest assignees by Innovation Score (46 here).

Atlassian, Inc. 46 Optim Corporation 46 Unity Semiconductor 46 ASP Global Manufacturing GmbH 46

Similar claim depth

Nearest assignees by average claims per patent (15.1 here).

Rolls-royce plc 15.1 avg Keygene N.V. 15.1 avg STI Holdings, Inc. 15.1 avg Hongfujin Precision Industry (WUHAN) Co., Ltd. 15.1 avg

Theravance's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

46 Top 21% higher than 79% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Theravance Biopharma R&D IP, LLC patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	39	16.3%
2016	22	9.2%
2017	27	11.3%
2018	23	9.6%
2019	29	12.1%
2020	24	10.0%
2021	20	8.4%
2022	14	5.9%
2023	27	11.3%
2024	7	2.9%
2025partial year	7	2.9%

Which technologies does Theravance Biopharma R&D IP, LLC patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 229

C07D - Heterocyclic Compounds 222

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 206

C07B - General Methods OF Organic CHEMISTRY; Apparatus Therefor 51

C07C - Acyclic OR Carbocyclic Compounds 38

C07F - Acyclic, Carbocyclic OR Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium OR Tellurium 13

C30B - Single-crystal Growth ; Unidirectional Solidification OF Eutectic Material OR Unidirectional Demixing OF Eutectoid MATERIAL; Refining BY Zone-melting OF Material ; Production OF A Homogeneous Polycrystalline Material With Defined Structure ; Single Crystals OR Homogeneous Polycrystalline Material WI 6

C07H - SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids 6

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 5

Y02P - Climate Change Mitigation Technologies IN THE Production OR Processing OF Goods 5

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 4

C12P - Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture 4

C09K - Materials FOR Miscellaneous Applications, NOT Provided FOR Elsewhere 2

A01N - Preservation OF Bodies OF Humans OR Animals OR Plants OR Parts Thereof ; Biocides, e.g. AS Disinfectants, AS Pesticides OR AS Herbicides ; Pest Repellants OR ATTRACTANTS; Plant Growth Regulators 2

Y10T - Technical Subjects Covered BY Former US Classification 1

Top 15 of 16 technology areas

Where it ranks

Overall rank by patents

#1,711

of 49,997 tracked assignees

Innovation Score

46.5 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Theravance Biopharma R&D IP, LLC's patent record in context - here's where to go next.

Theravance Biopharma R&D IP, LLC's lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 95.8% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #1,711 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Theravance Biopharma R&D IP, LLC against Dana Heavy Vehicle Systems Group, LLC, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 46.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.